ATHE Gets Funds For Parkinson's Research, No Safety Issues For QURE's Trial, TNXP On Watch

RTT News

by Super Admin 68 Views

Today's Daily Dose brings you news about Alterity securing funds for Parkinson's research, the Independent Data Monitoring Committee recommending ERYTECH's pancreatic cancer trial to continue, Ocugen's $23 million registered direct offering, uniQure's Huntington's disease trial, and Tonix Pharma's proposed diagnostic skin test to measure T cell immunity to SARS-CoV-2.